Acetylation of GOT2 at the K404 lysine residue promotes the proliferation of pancreatic cancer cells and tumor growth in vivo, and GOT2 acetylation at the lysine residue K159 is increased in human pancreatic tumors. This evidence concerns the gene GOT2 and pancreatic neoplasm.